Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

Broader health insurance and PBM sector stocks including Centene, CVS, Elevance Health and Humana decline as investors react ...

House Energy Chair Brett Guthrie said he hopes to revive the health legislation that was pushed out of the American Relief ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

Mattingly is an associate professor and vice chair of research in the Department of Pharmacotherapy at the University of Utah ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

UnitedHealth Group reported $5.5 billion in profit for the fourth quarter of 2024, on par with its haul a year prior. | ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Congress missed a chance at PBM reforms.